PNS276 DOES FDA BREAKTHROUGH DESIGNATION AFFECT HTA RECOMMENDATIONS IN TERMS OF TIMING AND OUTCOME?
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2176
https://www.valueinhealthjournal.com/article/S1098-3015(19)34554-1/fulltext
Section Title :
Section Order :
11889
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34554-1&doi=10.1016/j.jval.2019.09.2176